Higher Hospitalization Costs and Fewer Routine Discharges in the Medicaid Expansion Era for Lung Transplant Recipients

Andrew Kalra,Jessica M. Ruck,Alice L. Zhou,Armaan F. Akbar,Albert Leng,Bin You,Alfred J. Casillan,Jinny S. Ha,Christian A. Merlo,Errol L. Bush
DOI: https://doi.org/10.1111/ctr.70017
2024-11-13
Clinical Transplantation
Abstract:Background In January 2014, states expanded Medicaid access under the Affordable Care Act. We studied the financial implications of this policy on lung transplantation, a costly procedure. Methods Lung transplant (LT) hospitalizations were identified within the National Inpatient Sample (2005–2020). Recipients were categorized as "pre‐expansion" (1/2005–12/2013) versus "post‐expansion" (1/2014–12/2020) of Medicaid and as being in "expander" versus "non‐expander" regions. We calculated difference‐in‐differences estimates comparing pre‐ and post‐expansion eras in expander versus non‐expander regions for inflation‐adjusted hospitalization costs and for discharge disposition. We evaluated total hospitalization costs using multivariable generalized linear regression, adjusting for recipient demographics, Charlson Comorbidity Index, single versus double‐lung transplant, and extracorporeal membrane oxygenation (ECMO), ex‐vivo lung perfusion (EVLP), and mechanical ventilation usage. Results Of the 29 225 LT recipients identified, 14 085 were pre‐expansion and 15 140 were post‐expansion. More recipients were insured by Medicaid in expander n = 735 (9%) versus non‐expander n = 220, (3%) regions (p = 0.01) post‐expansion. Hospitalization costs increased post‐ versus pre‐expansion by 8713–$33 183, p
surgery,transplantation
What problem does this paper attempt to address?